Can cocoa prevent cardiovascular disease? Original paper

This long-term randomized controlled trial found that supplementation with cocoa extract reduced the risk of dying from cardiovascular disease.

This Study Summary was published on May 3, 2022.

Background

The likelihood that a person develops high blood pressure (hypertension) increases continuously with age.[1] This is noteworthy because hypertension is well established as playing a causal role in the development of cardiovascular disease (CVD).

A large number of studies looking at the effect of cocoa on blood pressure have been conducted, with a 2017 meta-analysis noting that cocoa leads to a small reduction in blood pressure.[3] Observational evidence has also found that eating a moderate amount of chocolate is associated with a lower risk of cardiovascular disease.[4] However, there has yet to be any clinical trial examining the effect of cocoa on cardiovascular disease outcomes.

The study

This randomized controlled trial examined the effect of cocoa extract on CVD events among 21,442 people (mean age of 72) without previous cardiovascular disease or cancer. The participants were assigned to take a supplement containing cocoa extract or a placebo daily. The cocoa extract supplement provided a daily dosage of 500 mg of flavanols (also known as flavan-3-ols), 80 mg of which were the subtype (–)-epicatechin, as well as roughly 50 mg of theobromine and 15 mg of caffeine.

The primary outcome was a composite of total CVD events, which included myocardial infarction, stroke, coronary revascularization, cardiovascular mortality, carotid artery surgery, peripheral artery surgery, and unstable angina requiring hospitalization. The latter three events were added after the start of the study due to lower than anticipated rates of CVD events. The secondary outcomes included CVD mortality, a combination of CVD events and all-cause mortality, each of the individual CVD events, and the original composite of CVD events (without the three that were added later). Other secondary outcomes included invasive cancer (excluding melanoma), breast cancer, colorectal cancer, and lung cancer. The median follow-up period was 3.6 years.

The results

Cocoa extract reduced the incidence of CVD mortality (a secondary outcome) by 27% (absolute risk reduction of 0.07%), major CVD events (an unplanned outcome measure) by 16% (absolute risk reduction of 0.12%), and had no effect on total cardiovascular events (the primary outcome). Other outcomes were not significantly different between groups.

Incidence of CVD mortality between groups

image

Note

This study received funding from Mars, a chocolate company.

The big picture

This trial provides some evidence that cocoa extract can reduce the risk of dying from cardiovascular disease. Still, this is currently the only randomized controlled trial looking at such an outcome, and there are important points to consider about its findings. The fact that CVD mortality was decreased, while total CVD events — the primary outcome — were not, is somewhat concerning. On the other hand, it’s possible that the very low rates of total CVD events in this trial (1.08% in the cocoa group and 1.2% in the placebo group) meant that it was underpowered to detect significant differences between groups. Additionally, it’s possible that cocoa primarily affects the more life-threatening types of CVD events.

The mechanism behind cocoa’s potential cardiovascular benefits are not known with certainty. Several studies suggest that cocoa supplementation can increase nitric oxide levels.[5][6][7] Nitric oxide has a number of beneficial effects on the vascular system, most notably inducing vasodilation, which perhaps explains why cocoa has been found to lower blood pressure and improve markers of vascular function.[8] Exactly how cocoa increases nitric oxide levels is hard to say, but some in vitro research suggests it could be at least partly the result of (–)-epicatechin increasing the activity of endothelial nitric oxide synthase (eNOS), an enzyme that synthesizes nitric oxide.[9][10][11]

The most biologically active component of cocoa is generally believed to be (–)-epicatechin. This study delivered 80 mg of (–)-epicatechin via a supplement. As seen in the table below, getting 80 mg of epicatechin from any one food would be difficult, but may be more feasible if a variety of the food sources are incorporated into the diet. For example, eating 1 ounce of dark chocolate, 2 medium-sized apples, 6 ounces of blackberries, and drinking 1 cup (8 ounces) of green tea would provide about 80 mg of (–)-epicatechin.

Common food sources of (–)-epicatechin

Food source(–)-Epicatechin per 100 grams/mL of foodAmount of food needed to obtain 80 mg of (–)-epicatechinNotes
Cocoa powder

image
158 to 196 mg
40 to 50 grams
(–)-Epicatechin content lower in alkalized cocoa
Dark chocolate

image
71 to 84 mg
95 to 113 grams
Milk chocolate

image
10.9 to 14.6 mg
548 to 800 grams
Red wine

image
3.8 mg
2.18 liters (74 ounces)
Red wine (Cabernet Sauvignon)

image
10.7 mg
0.75 liters (26.5 ounces)
Green tea

image
8.3 mg
0.96 liters (32 ounces)
Black tea

image
2.1 mg
3.76 liters (127 ounces)
Apple (Fuji)

image
5.7 mg
1.4 kg (3.1 pounds)
Higher amounts in skin than flesh
Blackberries

image
11.5 mg
0.7 kg (24.6 ounces)

References: Bhagwat and Haytowitz. 2016 https://doi.org/10.15482/USDA.ADC/1324465 | Neveu et al. 2010 Database, doi: 10.1093/database/bap024http://phenol-explorer.eu

Every month we summarize over 150 of the most noteworthy health and nutrition studies. Other health categories related to this summary include:Try Examine+ for free to view the latest research in 25 health categories and the entire Study Summaries archive, access our Supplement Guides, and unlock the Examine Database. Plus, earn continuing education credits!

Get free weekly updates on what’s new at Examine.

This Study Summary was published on May 3, 2022.

References

  1. ^Dariush Mozaffarian, Emelia J Benjamin, Alan S Go, Donna K Arnett, Michael J Blaha, Mary Cushman, Sarah de Ferranti, Jean-Pierre Després, Heather J Fullerton, Virginia J Howard, Mark D Huffman, Suzanne E Judd, Brett M Kissela, Daniel T Lackland, Judith H Lichtman, Lynda D Lisabeth, Simin Liu, Rachel H Mackey, David B Matchar, Darren K McGuire, Emile R Mohler 3rd, Claudia S Moy, Paul Muntner, Michael E Mussolino, Khurram Nasir, Robert W Neumar, Graham Nichol, Latha Palaniappan, Dilip K Pandey, Mathew J Reeves, Carlos J Rodriguez, Paul D Sorlie, Joel Stein, Amytis Towfighi, Tanya N Turan, Salim S Virani, Joshua Z Willey, Daniel Woo, Robert W Yeh, Melanie B Turner, American Heart Association Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics--2015 update: a report from the American Heart AssociationCirculation.(2015 Jan 27)
  2. ^Marjorie L McCullough, Kati Chevaux, Lilian Jackson, Mack Preston, Gregorio Martinez, Harold H Schmitz, Caroline Coletti, Hannia Campos, Norman K HollenbergHypertension, the Kuna, and the epidemiology of flavanolsJ Cardiovasc Pharmacol.(2006)
  3. ^Karin Ried, Peter Fakler, Nigel P StocksEffect of cocoa on blood pressureCochrane Database Syst Rev.(2017 Apr 25)
  4. ^Yongcheng Ren, Yu Liu, Xi-Zhuo Sun, Bing-Yuan Wang, Yang Zhao, De-Chen Liu, Dong-Dong Zhang, Xue-Jiao Liu, Rui-Yuan Zhang, Hao-Hang Sun, Fei-Yan Liu, Xu Chen, Cheng Cheng, Lei-Lei Liu, Qiong-Gui Zhou, Ming Zhang, Dong-Sheng HuChocolate consumption and risk of cardiovascular diseases: a meta-analysis of prospective studiesHeart.(2019 Jan)
  5. ^Christian Heiss, Petra Kleinbongard, Andrè Dejam, Sandra Perré, Hagen Schroeter, Helmut Sies, Malte KelmAcute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokersJ Am Coll Cardiol.(2005 Oct 4)
  6. ^Dirk Taubert, Renate Roesen, Clara Lehmann, Norma Jung, Edgar SchömigEffects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trialJAMA.(2007 Jul 4)
  7. ^Naomi D L Fisher, Meghan Hughes, Marie Gerhard-Herman, Norman K HollenbergFlavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humansJ Hypertens.(2003 Dec)
  8. ^Valeria Ludovici, Jens Barthelmes, Matthias P Nägele, Frank Enseleit, Claudio Ferri, Andreas J Flammer, Frank Ruschitzka, Isabella SudanoCocoa, Blood Pressure, and Vascular FunctionFront Nutr.(2017 Aug 2)
  9. ^Israel Ramirez-Sanchez, Lisandro Maya, Guillermo Ceballos, Francisco Villarreal(-)-epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide, and related signaling pathwaysHypertension.(2010 Jun)
  10. ^Israel Ramirez-Sanchez, Lisandro Maya, Guillermo Ceballos, Francisco Villarreal(-)-Epicatechin induces calcium and translocation independent eNOS activation in arterial endothelial cellsAm J Physiol Cell Physiol.(2011 Apr)
  11. ^Tatjana Brossette, Claas Hundsdörfer, Klaus-Dietrich Kröncke, Helmut Sies, Wilhelm StahlDirect evidence that (-)-epicatechin increases nitric oxide levels in human endothelial cellsEur J Nutr.(2011 Oct)